What banks can learn from Solvency II

Thomas Schubert and Gundula Griessmann, members of the German Insurance Association, argue that banks have more to learn from the insurance industry than they might care to admit

p58-graph-gif

When Solvency II, the new capital supervisory model for the insurance industry, is discussed, we often hear that banks already have more stringent risk management systems in place than insurance companies do. And because of that, we also often hear it claimed that Basel II, the newly agreed supervisory model for bank capital, could simply be transferred to the insurance industry.

But when we take a closer look, it becomes clear that the opposite is more likely to be the correct answer. The

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent Risk.net…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here